SSCA - A Sign of a Benign Pancreatic Tumor

· 1 min read
SSCA - A Sign of a Benign Pancreatic Tumor

A 3.5 cm solid polycyclic mass that isn't malignant is called an SSCA. It's a precursor lesion that isn't harmful to the pancreas and can signify a benign pancreatic tumor. Read on to learn more. Here is a breakdown of the different types of SSCA. Malignant tumors spread and invade nearby tissue. Benign tumors are benign and won't spread to other body parts.

SSCA

Solid serous cystadenoma (SSCA) is a rare subtype of benign pancreatic tumor. While its architecture differs from serous cystadenoma (SCA), the two types share similar immunological, cytological, and histopathologic features. Because of these similarities, they are often difficult to distinguish from each other. Because of these similarities, their management differs from those of other solid tumors.

SSCA is a benign pancreatic tumor

Solid serous cystadenoma (SSCA) is a type of pancreatic cyst that can present with several different histological findings. It differs from serous cystadenoma (SCA) and is relatively rare, accounting for about 1% to 2% of all pancreatic tumors. However, SCAs share similar immunological, cytological, and histological characteristics, making it difficult to differentiate between a variety of other solid pancreatic tumors. Although SCAs have a similar pathological appearance to renal cell carcinoma metastasis, the treatment of SSCA differs from those of other solid tumors.

SSCA is a precursor lesion

SSCA is a morphologically distinct precursor lesion of invasive pancreatic cancer. It is not always present in all patients but can be in up to half of all cases. There are two types of SSCA: mucinous cystic neoplasm and intraductal papillary mucinous neoplasm. SSCA does not preclude the possibility of other types of precursor lesions, including IPMN or MCN.

SSCA is a marker for ductal adenocarcinoma

Although SSCA is a useful marker for ductal adenocarcinoma, it is not a definitive test for determining whether a benign pancreatic tumor is malignant. Infiltrating adenocarcinoma is relatively rare, but it should be considered when other malignant conditions are suspected. It is a haphazard growth of infiltrating cells, often adjacent to vessels.